Chemistry (Nov 2023)

Bioactive Pyrrolo[2,1-<i>f</i>][1,2,4]triazines: Synthesis, Molecular Docking, In Vitro Cytotoxicity Assay and Antiviral Studies

  • Nataliya N. Mochulskaya,
  • Svetlana K. Kotovskaya,
  • Ilya I. Butorin,
  • Mikhail V. Varaksin,
  • Valery N. Charushin,
  • Vladimir L. Rusinov,
  • Yana L. Esaulkova,
  • Alexander V. Slita,
  • Polina A. Ilyina,
  • Vladimir V. Zarubaev

DOI
https://doi.org/10.3390/chemistry5040171
Journal volume & issue
Vol. 5, no. 4
pp. 2657 – 2676

Abstract

Read online

A series of 2,4-disubstituted pyrrolo[2,1-f][1,2,4]triazines containing both aryl and thienyl substituents were synthesized by exploiting the 1,3-cycloaddition reaction of N(1)-ethyl-1,2,4-triazinium tetrafluoroborates with dimethyl acetylenedicarboxylate. The antiviral activity of the synthesized compounds against influenza virus strain A/Puerto Rico/8/34 (H1N1) was studied in experiments on Madin-Darby canine kidney (MDCK) cell culture. Among the pyrrolo[2,1-f][1,2,4]triazine derivatives, compounds with low toxicity and high antiviral activity were identified. Dimethyl 4-(4-methoxyphenyl)-7-methyl-2-p-tolylpyrrolo[2,1-f][1,2,4]triazine-5,6-dicarboxylate was found to demonstrate the best antiviral activity (IC50 4 µg/mL and selectivity index 188). Based on the results of in vitro tests and molecular docking studies performed, a plausible mechanism of action for these compounds was suggested to involve inhibition of neuraminidase.

Keywords